Claire Dearden
Royal Marsden NHS Foundation Trust
ORCID: 0000-0001-7615-0468Also affiliated with Institute of Cancer Research, Royal Marsden Hospital
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Mirela Anghelina, Jasmine Neal, James S. Blachly, Puneet Mathur, Omkar Lele +38 more
Papers
Driven by 5 papers — median percentile 35. Top paper: “Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial”.
Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Tadeusz Robak +14 more
Leslie A. Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema A. Bhat, James S. Blachly +34 more
Mirela Anghelina, Jasmine Neal, James S. Blachly, Puneet Mathur, Omkar Lele +38 more
Robert J. Harris, Paolo Boffetta, Sílvia de Sanjosé, Guillem Clot, Larry Mansouri +92 more
Robert J. Kreitman, Enrico Tiacci, Leslie A. Andritsos, Versha Banerji, Jacqueline C. Barrientos +40 more